- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01983670
The Investigation of the Pre-movement Facilitation of Agonist-antagonist Muscles and the Effect of the Feedforward Rehabilitation in Individuals With Hypermetria
In individuals with spino-cerebellar atrophy (SCA), the delayed onset of antagonist muscle firing has been reported to be the cause of hypermetria. Hypermetria is a common deficit in individuals with spino-cerebellar atrophy SCA when they perform ballistic goal-directed movement. Based on the previous studies, ballistic goal-directed movements are controlled by a triphasic pattern of agonistic and antagonistic muscle activation. The origin of the EMG pattern is a central program, whereas the delayed onset of antagonistic muscle firing has been reported to be the cause of hypermetria. To develop a therapy method, the difference in temporal pattern and intensity of supraspinal excitability of agonist and antagonist bursts between healthy adults and individuals with SCA when performing rapid and slow goal-directed movements should be further investigated.
Traditional rehabilitations of individuals with cerebellum lesion were limited to improve the functional performance of movement. Since the deficits of the goal-directed movement are at pre-movement programming, only feedforward training will be possible to re-establish an appropriate program.
Previous showed that peripheral stimulation resulted in a facilitation of motor cortex. Our group also found that this facilitation in individuals with SCA was similar to the ones without SCA. Therefore, it is possible to adjust the control pattern of supraspinal excitability of agonist and antagonist busts of SCA patient with passively providing electrical stimulation contains normal control pattern of healthy human.
The present study sought to investigate the difference in temporal pattern and intensity of supraspinal excitability of agonist and antagonist bursts between healthy adults and individuals with SCA when performing rapid and slow goal-directed movements.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- Chang Gung University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of spinocerebellar ataxia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: health group 1
Health subjects received 30 mins delay antagonist activation temporal ES.
|
|
|
Experimental: SCA group 1
SCA subjects received four weeks temporal ES assisted home training program.
|
|
|
No Intervention: health group 2
health subjects controlled group
|
|
|
No Intervention: SCA group 2
SCA subjects controlled group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle evoked potential(MEP)
Time Frame: Baseline, 4 weeks.
|
Measure of changes in MEP of flexor carpi radialis.
|
Baseline, 4 weeks.
|
|
Electromyography(EMG)
Time Frame: Baseline, 4 weeks
|
Measure of changes in EMG of flexor carpi radialis and extensor carpi radialis.
|
Baseline, 4 weeks
|
|
Movement error
Time Frame: Baseline, 4weeks
|
Measure of changes in movement error during fast 30 degrees wrist extensions.
|
Baseline, 4weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Genetic Diseases, Inborn
- Neurodegenerative Diseases
- Dyskinesias
- Spinal Cord Diseases
- Heredodegenerative Disorders, Nervous System
- Cerebellar Diseases
- Ataxia
- Cerebellar Ataxia
- Spinocerebellar Ataxias
- Spinocerebellar Degenerations
Other Study ID Numbers
- 98-0951B
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinocerebellar Atrophy (SCA)
-
University of FloridaRaynor Cerebellum ProjectNot yet recruitingSpinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia (SCA)United States
-
University of California, San FranciscoRaynor Cerebellum ProjectRecruitingSpinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia (SCA)United States
-
Chang Gung UniversityRecruiting
-
Biohaven Pharmaceuticals, Inc.AvailableSpinocerebellar Ataxias | SCA
-
Laura Alice Santos de OliveiraFederal Institute of Rio de JaneiroEnrolling by invitationGait Ataxia | Postural Balance | SCABrazil
-
First Affiliated Hospital of Fujian Medical UniversityCompletedSpinocerebellar Ataxia Type 3 | Multiple System Atrophy-cerebellar TypeChina
-
University of FloridaAcorda TherapeuticsCompletedSpinocerebellar Ataxias Type 1 | Spinocerebellar Ataxias Type 2 | Spinocerebellar Ataxias Type 3 | Spinocerebellar Ataxias Type 6United States
-
Cadent TherapeuticsWithdrawnSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8 | Spinocerebellar Ataxia Type 17 | ARCA1 - Autosomal Recessive...United States
-
Biohaven Pharmaceuticals, Inc.CompletedSpinocerebellar Ataxias | Spinocerebellar Ataxia Genotype Type 1 | Spinocerebellar Ataxia Genotype Type 2 | Spinocerebellar Ataxia Genotype Type 3 | Spinocerebellar Ataxia Genotype Type 6 | Spinocerebellar Ataxia Genotype Type 7 | Spinocerebellar Ataxia Genotype Type 8 | Spinocerebellar Ataxia Genotype...United States
-
Samsung Medical CenterCompletedSpinocerebellar Ataxias | Multiple System Atrophy, Cerebellar Variant (Disorder)Korea, Republic of
Clinical Trials on Temporal electrical stimulation
-
Indiana UniversityNational Institute of Mental Health (NIMH)RecruitingHealthy VolunteersUnited States
-
Ke Dong, MDSun Yat-sen UniversityRecruitingParkinson Disease | Parkinson Disease, SecondaryChina
-
Indiana UniversityNational Institute of Mental Health (NIMH)RecruitingHealthy VolunteersUnited States
-
Indiana UniversityNational Institute of Mental Health (NIMH)RecruitingHealthy VolunteersUnited States
-
University of Wisconsin, MadisonRecruitingHealthy ParticipantsUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBipolar DepressionChina
-
Jiangsu Province Nanjing Brain HospitalNot yet recruitingPARKINSON DISEASE (Disorder)China
-
The Second Hospital of Anhui Medical UniversityRecruitingDepressive Disorder | Temporal Interference StimulationChina
-
YangPanRecruitingParkinson's Disease | Movement DisordersChina
-
First Affiliated Hospital of Zhejiang UniversityRecruiting